z-logo
open-access-imgOpen Access
Frequency of thrombocytopenia and its association with mortality among neonates having probable or culture proven sepsis.
Author(s) -
Shakeel Ahmad,
Nusrat Hussain,
Tayyaba Rafique,
Rabia Saleem
Publication year - 2020
Publication title -
the professional medical journal/the professional medical journal
Language(s) - English
Resource type - Journals
eISSN - 2071-7733
pISSN - 1024-8919
DOI - 10.29309/tpmj/2020.27.12.4520
Subject(s) - medicine , sepsis , neonatal sepsis , neonatology , platelet , pediatrics , blood culture , pregnancy , antibiotics , biology , microbiology and biotechnology , genetics
Objectives: To determine frequency of thrombocytopenia and its association with mortality among neonates having probable or culture proven sepsis. Study Design: Descriptive Analytical study. Setting: Multicentre study done at Neonatology Unit of Teaching Hospital Dera Ghazi Khan and Nishtar Medical University, Multan. Period: February 2019 to July 2019. Material & Methods: Three hundred neonates with culture proven sepsis were enrolled. Platelet counts along with frequency of thrombocytopenia (<150000/mm3) and mortality among all the neonates were recorded. Mortality among different groups according to platelet counts was compared adopting chi-square test. Results: Out of 300 neonates considered in the final analysis, 164 (54.7%) were male. Overall, median platelet count was 213.0mm3. TCP was present in 78 (26.0%) cases. Among 146 culture proven sepsis cases, 88 (61.8%) had gram positive while 58 (38.2%) had gram negative pathogens. Cases having thrombocytopenia had significantly higher mortality (n=26/78, 33.3%) as compared with those who had normal or increased platelet count (n=25/222, 11.3%) representing a significant p value (<0.00001). Conclusion: Thrombocytopenia is a common complication of culture proven and probable neonatal sepsis. Mortality is significantly high in neonatal sepsis along with thrombocytopenia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here